ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1169

Association between Depressive Symptom Subtypes and Disease Severity in Knee Osteoarthritis

Alan Rathbun1, Megan Schuler2, Elizabeth Stuart3, Michelle Shardell4, Michelle S. Yau5, Joseph Gallo6 and Marc C. Hochberg7, 1Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, 2Rand Coportation, Boston, MA, 3Mental Health, Biostatistics, and Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 4Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, 5Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, 6Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 7University of Maryland School of Medicine, Baltimore, MD

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: depression, functional status, Knee, osteoarthritis and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Epidemiology and Public Health Poster II – ARHP

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Latent and modifiable factors, such as depressive symptoms, may affect the course of knee OA. Depression is clinically heterogeneous, and effects on pain and disability may manifest differently by depressive symptom subtypes. This study evaluated trajectories of pain and disability by depressive symptom subtypes among individuals who have or are at risk for knee OA.   Methods: Participants (n=4486) were enrolled in the Osteoarthritis Initiative. Latent class analysis was applied to the 20-Item Center for Epidemiological Studies Depression Scale measured at baseline and used to assign participants to one of four depressive symptom subtypes identified previously (“No Symptoms”, “Catatonic”, “Anhedonic”, and “Melancholic”). OA disease severity was assessed annually over four years using the pain and disability subscales (rescaled range = 0-100) of the WOMAC. Analyses were stratified by those with (n=1626) and without (n=2860) symptomatic knee OA at baseline, defined as pain on most days of a month in the past 12 months. Propensity score weights were used to balance the four depressive symptom subtypes on baseline confounders: age, sex, race, education, smoking status, alcohol consumption, health insurance, employment status, BMI, Kellgren-Lawrence grade, history of knee injury, analgesic use, and total WOMAC score. Non-response weights were computed with logistic regression and were used to account for missing data. Weighted estimating equations were used to estimate pain and disability trajectories and to evaluate between-group differences in disease severity by baseline depressive symptom subtype during the follow-up period.   Results: Among participants with symptomatic knee OA, the “Melancholic” depressive symptom subtype had more severe pain (β=3.61; 95% CI: -0.15, 7.39; P=0.060) and significantly greater disability (β=5.36; 95% CI: 1.41, 9.32; P=0.007) than the “No Symptoms” subtype (Table 1). In individuals without symptomatic knee OA, the “Anhedonic” subtype had significantly worse pain (β=1.33; 95% CI: 0.20, 2.47; P=0.020) and disability (β=1.34; 95% CI: 0.27, 2.42; P=0.014) compared to the “No Symptoms” subtype (Table 1). Differences in pain and disability between the “Catatonic” and “No Symptoms” subtypes were small and not statistically significant in both participants with and without symptomatic knee OA.     Conclusion: Findings indicate that the effects of depressive symptoms on pain and disability are largest in persons with symptomatic knee OA who exhibit “Melancholic” symptomology. “Melancholic” depressive symptoms are characterized by the inability to feel pleasure, decreased energy and movement, and somatic complaints; and thus, may be a modifiable risk factor for worsening disease severity and potential target for intervention in patients with symptomatic knee OA.       

         

Table 1. Differences in pain and disability by baseline depressive symptom subtype among Osteoarthritis Initiative participants with (n=1626) and without (n=2860) symptomatic knee OA over four years of follow-up.

Depressive Symptom Subtype

Pain

Disability

Symptomatic OA

β

95% CI

P Value

β

95% CI

P Value

No Symptoms

REF

REF

REF

REF

REF

REF

Catatonic

-0.09

-3.10, 2.91

0.950

0.10

-2.87, 3.07

0.945

Anhedonic

0.19

-2.11, 2.51

0.867

0.42

-1.79, 2.65

0.705

Melancholic

3.61

-0.15, 7.39

0.060

5.36

1.41, 9.32

0.007

Non-symptomatic OA

β

95% CI

P Value

β

95% CI

P Value

No Symptoms

REF

REF

REF

REF

REF

REF

Catatonic

0.76

-0.81, 2.34

0.340

0.11

-1.13, 1.35

0.862

Anhedonic

1.33

0.20, 2.47

0.020

1.34

0.27, 2.42

0.014

Melancholic

1.30

-1.08 3.69

0.284

1.83

-0.48, 4.15

0.120

     

Disclosure: A. Rathbun, None; M. Schuler, None; E. Stuart, None; M. Shardell, None; M. S. Yau, None; J. Gallo, None; M. C. Hochberg, Bioberica, 5,EMD Serono, 5,Novartis Pharma AG, 5,Plexxikon, 5,Pfizer, Inc., 5,Proximagen, 5,Regeneron, 5,Samumed, LLC, 5,Theralogix LLC, 5.

To cite this abstract in AMA style:

Rathbun A, Schuler M, Stuart E, Shardell M, Yau MS, Gallo J, Hochberg MC. Association between Depressive Symptom Subtypes and Disease Severity in Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/association-between-depressive-symptom-subtypes-and-disease-severity-in-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-depressive-symptom-subtypes-and-disease-severity-in-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology